규제 업데이트
2026년 9월 25일•1분 읽기
FDA Approves Dexamethasone Sodium Phosphate Injection (ANDA 084282)
The FDA has approved ANDA 084282 for Dexamethasone Sodium Phosphate injectable, a prescription drug manufactured by Hikma and Civica with multiple NDC listings.
규제 업데이트
2026년 8월 29일•1분 읽기
Watson Labs' Dexamethasone Sodium Phosphate Injection Discontinued (ANDA083702)
Watson Labs' injectable dexamethasone sodium phosphate (product 001) is listed as discontinued per FDA ANDA083702 filing.